GE Healthcare UK interview (I): Using the early health model to transform healthcare delivery
This article was originally published in Clinica
Executive Summary
GE Healthcare has evolved over the last decade from a product-focused company into a provider of a range of diagnostic capabilities to address a disease or condition, frequently in consultation with national healthcare decision-makers. Now on the threshold of another major expansion, bringing divisions of Abbott Laboratories into the fold, and with its strengths in molecular medicine and a combined in vitro and in vivo approach to diagnostics, the group has a unique role to play in the way modern healthcare is delivered, Nigel Mason, president of GE Healthcare UK, told Ashley Yeo
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.